Different injectable vaccines should always be given at different vaccination sites.
Do not mix Prevenar 20 with other vaccines/medicinal products in the same syringe.
Paediatric population: In infants and children, 6 weeks to less than 5 years of age, Prevenar 20 can be administered concomitantly with any of the following vaccine antigens, either as monovalent or combination vaccines: diphtheria, tetanus, acellular pertussis, hepatitis B, Haemophilus influenzae type b, inactivated poliomyelitis, measles, mumps, rubella, and varicella vaccines. In clinical trials, rotavirus vaccines were permitted to be administered concomitantly with Prevenar 20 and no safety concerns were observed.
Individuals 18 years of age and older: Prevenar 20 can be administered concomitantly with influenza vaccine, adjuvanted (Fluad Quadrivalent [QIV]) and COVID 19 mRNA vaccine (nucleoside modified) (see Pharmacology: Pharmacodynamics under Actions).
No data are currently available regarding concomitant use with other vaccines.